United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2026 financial results ...

Company to host conference call and webcast on November 5, 2026, at 8:00 a.m. ET (9:00 p.m. HKT) SHANGHAI & CAMBRIDGE, Mass.- ...

(Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule ...

Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, ...

Agencies aligned on trial design, endpoints and safety database; FDA agreed NDA-enabling studies can run in parallel with ...

Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people ...

Patient-derived liver and intestinal disease models are designed to help drug developers test whether a candidate reduces ...

New research led by the University of Colorado Anschutz is offering hope to people living with stiff person syndrome (SPS), ...

Robin Swartz, Voyager’s Chief Business and Operating Officer, appointed President, effective immediately; expected to succeed ...

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced the acceptance of 12 ...

Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, ...

Fenebrutinib FENtrepid and FENhance 1 & 2 late-breaking data demonstrate a therapeutic effect on chronic active lesions, ...